Sign in

CLYD

BEACON TOPCO, INC.

BEACON TOPCO, INC. is an American pharmaceutical preparations company, incorporated in Delaware.1 It is headquartered in Germantown, Maryland.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerCLYD1
  • IndustryPharmaceutical Preparations1
  • HeadquartersGermantown, Maryland1
  • Incorporated inDE2
  • Business address20400 Century Boulevard, Suite 210, Germantown, Md 208742
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Corporate structure

BEACON TOPCO, INC. is part of a group headed by Barinthus Biotherapeutics plc.. 9 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Barinthus Biotherapeutics plc. Altrincham, United Kingdom
    • BEACON TOPCO, INC. Germantown, Maryland
    • BARINTHUS BIOTHERAPEUTICS (UK) LIMITED Subsidiary · 75% · Oxford, United Kingdom
    • Barinthus Biotherapeutics (UK) Limited (formerly Vaccitech (UK) Limited) Subsidiary · United Kingdom
    • Barinthus Biotherapeutics North America, Inc. (formerly Vaccitech North America, Inc.) Subsidiary · Delaware, United States
    • Barinthus Biotherapeutics Pty Limited (formerly Vaccitech Australia Pty Limited) Subsidiary · Australia
    • Barinthus Biotherapeutics Switzerland GmbH (formerly Vaccitech Switzerland GmbH) Subsidiary · Switzerland
    • Cdog Merger Sub, Inc. Subsidiary · Delaware, United States
    • Vaccitech Oncology Limited Subsidiary · United Kingdom

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC. Each entity in the chart links to its source.

Timeline

  1. Sep 24, 20268-K Entered a material agreement; Other events3
  2. Sep 17, 20268-K Change to shareholders' rights; Bylaws or fiscal year changed4

Filings

16 filings to the SEC since October 2021: 2 quarterly reports, 2 major events, 12 other. The latest 16:

  1. Oct 13, 2026SC TO-I/A EDGAR
  2. Sep 29, 2026SC TO-I/A EDGAR
  3. Sep 24, 20268-K EDGAR
  4. Sep 24, 2026SC TO-I/A EDGAR
  5. Sep 17, 20268-K EDGAR
  6. Sep 15, 2026SC TO-I EDGAR
  7. Jul 14, 202610-Q EDGAR
  8. Jul 2, 2026SP 15D2 EDGAR
  9. Jun 5, 202610-Q EDGAR
  10. Apr 23, 2026424B3 EDGAR
  11. Apr 22, 2026EFFECT EDGAR
  12. Apr 13, 2026S-4/A EDGAR
  13. Mar 31, 2026S-4/A EDGAR
  14. Mar 13, 2026S-4/A EDGAR
  15. Jan 27, 2026S-4/A EDGAR
  16. Nov 7, 2025S-4 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How BEACON TOPCO, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBEACON TOPCO, INC.1
  • CIK0002094256
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address20400 Century Boulevard, Suite 210, Germantown, MD 208741
  • Phone44391709661
  • Shares outstanding100 as of Jul 10, 20265
  • On EDGAR sinceNov 7, 20251
  • Filings16 in all: S-4/A (4), SC TO-I/A (3), 10-Q (2), 8-K (2), 424B3 (1), EFFECT (1), S-4 (1), SC TO-I (1)1
    All 9 form types

    SP 15D2 (1)

  • Latest filingsQuarterly report (10-Q) Jul 14, 2026
    Latest 8-K (8-K) Sep 24, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5